Submitted by Anonymous (not verified) on 21 May 2024 - 15:25
Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 3, Status: Authorised